Skip to content

Anthera Pharmaceuticals Inc

CIK 0001316175

← back to feed
Revenue (TTM)
$1.41M
0.0% YoY Q1 Apr 2018
Net Income (TTM)
−$24.93M
−107.0% YoY Q1 Apr 2018
EPS Diluted (TTM)
—
Q1 Apr 2018
Gross Margin
—
Q1 Apr 2018
Operating Margin
-2,701.7%
Q1 Apr 2018
Net Margin
-1,765.2%
Q1 Apr 2018
Free Cash Flow (TTM)
−$36.36M
Q1 Apr 2018
Cash
$8.09M
Q1 Apr 2018
Total Debt
$18.1M
Q1 Apr 2018
Shares Outstanding
26.18M sh
Q1 Apr 2018

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings